Residual Stroke Risk in Atrial Fibrillation
Wern Yew Ding
Abstract
AF contributes to increased stroke risk via various mechanisms, including deranged blood constituents, vessel wall abnormalities and abnormal blood flow. This excess risk is frequently managed with anticoagulation therapy, aimed at preventing thromboembolic complications. Yet, a significant proportion of patients with AF remain at high residual stroke risk despite receiving appropriate dose-adjusted anticoagulation. This article explores the residual stroke risk in AF and potential therapeutic options for these patients.
Topics & Concepts
Atrial fibrillationStroke riskStroke (engine)MedicineResidual riskCardiologyEmbolic strokeInternal medicineThromboembolic strokeIschemic strokeIntensive care medicineIschemiaEngineeringMechanical engineeringAtrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsAntiplatelet Therapy and Cardiovascular Diseases